Across TCGA pan-cancer cohorts, FABP12P1 RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated FABP12P1 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher FABP12P1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated FABP12P1 expression acts as an unfavorable survival marker, although some lineages such as SKCM show a favorable association.

OV, THCA, and SKCM are the cancer types where FABP12P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Tertile	IV	0.007	0.760	<.001	102	view →
THCA	DFS	Tertile	All	0.136	0.842	.002	36	view →
SKCM	DFS	Tertile	All	0.681	0.200	.022	12	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: FABP12P1 tumor-vs-normal RNA expression · all FABP12P1 data types